Clinical Trials Browser

Recruiting × Carcinoma, Non-Small-Cell Lung × Immune Checkpoint Inhibitors × Clear all

NCT04913311 2026-02-19

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT05522660 2025-12-11

USZ-STRIKE

Phase 3 Recruiting

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT06896422 2025-08-07

Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05486650 2025-07-14

An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment

Carcinoma, Non-Small-Cell Lung

NCT06977074 2025-05-23

PROPHET

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04977791 2025-05-22

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT06730503 2024-12-12

Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT06388031 2024-11-07

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05014464 2024-09-20

ATPase

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04322578 2024-06-04

CONFIRM

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05037825 2022-04-27

PARADIGM

BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms